NZACRes 2017 Conference

Silver Sponsors

GSK is a research-based pharmaceutical and healthcare company operating in more than 100 countries around the world. Our Mission is to improve the quality of human life by enabling people to do more, feel better and live longer. As part of this commitment, we recognise the valuable role that our support of Investigator-Sponsored Studies (ISS) plays in fulfilling this mission. An ISS is a research effort where the sponsor of the work is an investigator, healthcare institution, or some form of medical network external to GSK and is seeking our support to conduct the work. This support can be in the form of product, funding, or a combination of both. Come to the GSK stand to find out more about how we can support your local Kiwi research.

Novotech is internationally recognised as Asia Pacific’s leading full-service contract research organisation (CRO) operating. Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials throughout the region. Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management. Novotech’s strong Asia Pacific presence included running clinical trials in all key regional markets. Novotech also has worldwide reach through the company's network of strategic partners.

Bronze Sponsors





IGENZ is an accredited medical testing laboratory located in Auckland, New Zealand. The laboratory has an interest in targeted cancer testing and supplies services mainly for clinical diagnostics however is also involved in translational (applied) research. Recently IGENZ purchased a genetic profiling laboratory to extend its testing scope.

P3 Research Ltd is a leading provider of sponsored clinical research in New Zealand. It is a dedicated Clinical Trials Company specialising in phase 2 and 3 clinical trials in common, chronic, relatively stable conditions normally managed in primary care. Since 2001 we have provided high quality reliable services to both large and small Pharma and Biotech companies. We operate from three distinct Sites in New Zealand (Wellington, Tauranga and Hawkes Bay), which gives us access to large numbers of potential volunteers. We have particular expertise in phase 2 COPD and asthma studies but our experience also covers a wide variety of other therapeutic areas including type 2 diabetes, flu vaccines, chronic pain and dermatological conditions.

PHARMAC is the New Zealand Government agency that decides which medicines, medical devices and related products are subsidised, both in the community and public hospitals. PHARMAC’s job is to ensure that New Zealanders get the best possible health outcomes from money the Government spends on pharmaceuticals (this includes medicines, therapeutic medical devices and related products). The funding for the subsidies comes from District Health Boards. PHARMAC’s activity to manage this spend, while at the same time achieving best health outcomes, is important to ensuring the long-term sustainability of the health system.

RealTime Software Solutions continues to grow its global footprint with innovative, user-friendly solutions that bring streamlined processes and greater profitability to clinical research sites. RealTime offers powerful innovations such as leading clinical trial management systems for standalone sites and multi-site organizations (RealTime-CTMS), automated TEXT messaging (RealTime-TEXT), stipend payment portals (RealTime-PAY), eRegulatory solutions (eDOCS), and electronic source (RealTime-eSOURCE). Further, RealTime is the only software provider that can package these solutions separately or fully-integrated, allowing customers to add on solutions as needed to streamline their organization as they grow. Partnering with RealTime will help your site stand out and lead the pack.

Catering Sponsor

At Quintiles we help healthcare and biopharma companies improve their probability of success. We do this by connecting our scientific, therapeutic and analytics expertise with superior delivery. From advisory through operations, Quintiles and its affiliate companies is the world’s largest provider of product development and integrated healthcare services. As one of FORTUNE’s ‘Most Admired Companies’ in 2016, we offer great opportunities for a career in world-leading clinical research. Our global projects, innovative tools and industry leading customers combined with outstanding support from our leadership team and clear career mapping allows you to make a difference in patient health.

Supporting Sponsors

Christchurch Clinical Studies Trust (CCST) was establishment in 1999 when it was identified that there was a need for a well-designed dedicated facility to perform Phase I and II pharmacokinetic and pharmacodynamic studies in healthy volunteers and patient populations. CCST has conducted over 100 clinical trials and we have become known as a centre of excellence for Phase 1 healthy volunteer and renal impairment studies. The healthy volunteer studies have ranged from entry-in-human, single ascending dose trials to bioequivalence/food effect studies and more recently biosimilar studies. Many of these studies have been a “critical path” for the sponsors and the development of new novel therapies.

Clinical Trials NZ Ltd (formerly Waikato Clinical Research) is a free standing clinical trials unit which specialises in Phase 1 to Phase 4 clinical trials. CTNZ has credible experience with both in-patient and out-patient trials, and conducts trials in the areas of acute and post-operative pain, Dermatology, Vascular, medical devices and Ophthalmology. With over 30 years of conducting trials, having leading medical specialists and access to hospitals of world class facilities we can offer efficiently run clinical trials in a first world environment. CTNZ nurses are all dedicated clinical trials co- coordinators trained in ICH/ GCP. Our clinical trials have been presented at International meetings in the USA, Europe and Australasia.

Pacific Clinical Research Network (PCRN) has been formed to achieve faster delivery with consistent quality across multiple clinical trial sites in Australia and New Zealand. PCRN is a partnership between Southern Clinical Trials Group (NZ), Lakeland Clinical Trials (NZ) and Paratus Clinical Trials (Australia). PCRN will provide a single contact point for sponsors, centralised feasibility and start up processes and a common suite of SOPs, quality systems and processes across the Alliance.